Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients

This study has been completed.

Study NCT00072618 Information provided by OSI Pharmaceuticals

First Received: November 5, 2003 Last Updated: October 10, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	August 2003
Estimated Primary Completion Date:	No date given